Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
03/06/2024 | 22:30 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | AMEX:AZTR | Azitra Inc |
31/05/2024 | 14:00 | Business Wire | Azitra, Inc. Announces Presentation at the 2024 BIO International Convention | AMEX:AZTR | Azitra Inc |
24/05/2024 | 22:55 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | AMEX:AZTR | Azitra Inc |
17/05/2024 | 14:00 | Business Wire | Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting | AMEX:AZTR | Azitra Inc |
10/05/2024 | 14:00 | Business Wire | Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting | AMEX:AZTR | Azitra Inc |
09/05/2024 | 23:05 | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:AZTR | Azitra Inc |
09/05/2024 | 23:03 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | AMEX:AZTR | Azitra Inc |
09/05/2024 | 23:00 | Business Wire | Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates | AMEX:AZTR | Azitra Inc |
22/04/2024 | 22:30 | Business Wire | Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting | AMEX:AZTR | Azitra Inc |
18/04/2024 | 22:15 | Business Wire | Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024 | AMEX:AZTR | Azitra Inc |
15/03/2024 | 21:15 | Business Wire | Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates | AMEX:AZTR | Azitra Inc |
26/02/2024 | 22:10 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | AMEX:AZTR | Azitra Inc |
26/02/2024 | 22:05 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | AMEX:AZTR | Azitra Inc |
16/02/2024 | 22:05 | Business Wire | Azitra, Inc. Announces Closing of Public Offering | AMEX:AZTR | Azitra Inc |
16/02/2024 | 02:42 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:AZTR | Azitra Inc |
15/02/2024 | 22:44 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | AMEX:AZTR | Azitra Inc |
14/02/2024 | 04:09 | Business Wire | Azitra, Inc. Announces Pricing of Public Offering | AMEX:AZTR | Azitra Inc |
19/01/2024 | 17:08 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses | AMEX:AZTR | Azitra Inc |
19/01/2024 | 15:19 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under the Securities Act of 1933 | AMEX:AZTR | Azitra Inc |
16/01/2024 | 15:00 | Business Wire | Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US | AMEX:AZTR | Azitra Inc |
03/01/2024 | 15:00 | Business Wire | Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference | AMEX:AZTR | Azitra Inc |
04/12/2023 | 22:06 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | AMEX:AZTR | Azitra Inc |
14/11/2023 | 22:30 | Business Wire | Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates | AMEX:AZTR | Azitra Inc |
16/10/2023 | 14:00 | Business Wire | Azitra to Present at the ThinkEquity Conference | AMEX:AZTR | Azitra Inc |
29/08/2023 | 14:00 | PR Newswire (US) | Azitra to Present at the H.C. Wainwright 25th Annual Global Investment Conference | AMEX:AZTR | Azitra Inc |
14/08/2023 | 22:05 | PR Newswire (US) | Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates | AMEX:AZTR | Azitra Inc |
19/07/2023 | 22:05 | PR Newswire (US) | Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of Directors | AMEX:AZTR | Azitra Inc |
11/07/2023 | 22:05 | PR Newswire (US) | Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer | AMEX:AZTR | Azitra Inc |
03/07/2023 | 21:04 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial ownership | AMEX:AZTR | Azitra Inc |
29/06/2023 | 22:57 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/a) | AMEX:AZTR | Azitra Inc |